Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis
The Chinese herb Dichroa febrifuga has traditionally treated malaria-associated fever. Its active component febrifugine (FF) and derivatives such as halofuginone (HF) are potent anti-malarials. Here, we show that FF-based derivatives arrest parasite growth by direct interaction with and inhibition o...
Asıl Yazarlar: | Jain, V, Yogavel, M, Oshima, Y, Kikuchi, H, Touquet, B, Hakimi, M, Sharma, A |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
Cell Press
2015
|
Benzer Materyaller
-
Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis.
Yazar:: Jain, V, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
Yazar:: Mark A. Tye, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01) -
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
Yazar:: Manickam Yogavel, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01) -
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
Yazar:: Manickam Yogavel, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01) -
Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
Yazar:: Yogavel Manickam, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)